Council adopts ‘compassionate’ approach to obesity and rejects weight-loss goals
Doncaster Council’s new approach aims to alleviate blame from overweight people and respect the “inherent diversity” of body ...
Obesity drug developer BioAge seeks up to $587 mln valuation in US IPO
Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...
Impacts2d
Discover The Benefits Of Adding Obesity ETFs To Your Portfolio In 2024
Exchange-traded funds, commonly known as ETFs, are security baskets where a collection of investments is pooled. Like stocks, ...
Weight loss drug liraglutide shows promise for younger children with obesity, study finds
Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got ...
News Medical8d
Obesity medication liraglutide is safe and effective in children aged 6 to <12 years
Liraglutide treatment significantly lowers BMI in obese children aged 6 to <12, but gastrointestinal side effects prompt the ...
FierceBiotech10d
‘The trajectory is encouraging.’ Roche hopes obesity drug will show 25% weight loss one day
Roche is holding out hopes that its injectable obesity prospect could eventually demonstrate 25% weight loss in late-stage ...
WLWT9d
Weight loss drug liraglutide shows promise for younger children with obesity, study finds
The trial included 82 children, of whom 56 got a liraglutide injection once a day. The rest got a placebo ... with the research. Developing anti-obesity medicine for children is complicated ...